Intra-lesional Tumor Boost for Bulky Cervical Cancer
Recruiting
Phase 2
Interventional Study
Cervical Cancer
Squamous Cell Carcinoma of Cervix
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 19 – 80
- Sex
- Female
- Trial phase
- Phase 2
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 17 (estimated)
- Sponsor
- Seoul National University Bundang Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this clinical trial is to learn if adding a radiation boost (intra-lesional boost) works to treat patients with large-sized cervical cancer. It will also learn about the safety of this treatment. The main questions it aims to answer are:
* Does the extra radiation boost effectively reduce the tumor size before the internal radiation (brachytherapy) treatment begins?
* What medical pro…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients with histologically confirmed squamous cell carcinoma of the cervix.
* Patients with bulky primary tumor, defined as a tumor volume ≥ 60 cc OR a maximum diameter ≥ 6 cm.
* Patients aged 19 to 80 years at the time of diagnosis.
* Patients with an ECOG performance statu…
Contacts